Copyright
©The Author(s) 2024.
World J Orthop. Jul 18, 2024; 15(7): 627-634
Published online Jul 18, 2024. doi: 10.5312/wjo.v15.i7.627
Published online Jul 18, 2024. doi: 10.5312/wjo.v15.i7.627
Parameter | Overall cohort | Relapsed postop | Abstinent postop | P value |
Number of patients | 37 | 21 | 16 | |
Total knee replacement | 17 (45.9) | 12 (57.1) | 5 (31.2) | 0.22 |
Average age in yr (SD) | 60.62 (11.90) | 62.76 (12.32) | 57.81 (11.08) | 0.22 |
Male | 15 (40.5) | 9 (42.9) | 6 (37.5) | 1.00 |
Race | 0.62 | |||
African American | 10 (27.0) | 5 (23.8) | 5 (31.2) | |
Caucasian | 26 (70.3) | 15 (71.4) | 11 (68.8) | |
Other | 1 (2.7) | 1 (4.8) | 0 (0.0) | |
Marital status | 0.36 | |||
Divorced | 6 (16.2) | 5 (23.8) | 1 (6.2) | |
Married | 21 (56.8) | 10 (47.6) | 11 (68.8) | |
Single | 9 (24.3) | 5 (23.8) | 4 (25.0) | |
Widowed | 1 (2.7) | 1 (4.8) | 0 (0.0) | |
Average BMI (SD) | 29.96 (6.86) | 30.53 (6.75) | 29.20 (7.17) | 0.58 |
Average ASA (SD) | 2.43 (0.55) | 2.52 (0.60) | 2.31 (0.48) | 0.26 |
Hospital LOS in d (SD) | 2.76 (1.92) | 2.90 (2.21) | 2.56 (1.50) | 0.6 |
Follow up mean (SD) | 2.85 (1.93) | 2.65 (2.20) | 3.11 (1.53) | 0.48 |
Parameter | Overall cohort | Relapsed postop | Abstinent postop | P value |
Number of patients | 37 | 21 | 16 | |
Tobacco use preoperatively | 0.66 | |||
Cigarettes | 32 (86.5) | 18 (85.7) | 14 (87.5) | |
Cigars | 4 (10.8) | 2 (9.5) | 2 (12.5) | |
Other | 1 (2.7) | 1 (4.8) | 0 (0.0) | |
Provider requested tobacco abstinence preoperatively | 0.34 | |||
Yes | 31 (83.8) | 19 (90.5) | 12 (75.0) | |
No | 5 (13.5) | 2 (9.5) | 3 (18.8) | |
Can't remember | 1 (2.7) | 0 (0.0) | 1 (6.2) | |
PPD prior to cessation efforts (SD) | 0.74 (0.52) | 0.80 (0.55) | 0.68 (0.48) | 0.51 |
Complete tobacco abstinence preoperatively | 27 (73.0) | 15 (71.4) | 12 (75.0) | 1.00 |
PPD preoperatively after cessation efforts | 0.06 (0.12) | 0.08 (0.14) | 0.04 (0.10) | 0.49 |
Time until tobacco relapse in mo (SD) | 2.73 (1.82) | 2.73 (1.82) | Not Applicable | |
Cessation method | 0.55 | |||
Nothing | 24 (64.9) | 12 (57.1) | 12 (75.0) | |
Prescription medication | ||||
Varenicline | 2 (5.4) | 2 (9.5) | 0 (0.0) | |
Bupropion | 3 (8.1) | 1 (4.8) | 2 (12.5) | |
Nicotine replacement | 7 (18.9) | 6 (28.6) | 1 (6.2) | |
Counseling | 2 (5.4) | 2 (9.5) | 0 (0.0) | |
Gum or mints | 2 (5.4) | 0 (0.0) | 2 (12.5) | |
Current tobacco use | 19 (51.4) | 19 (90.5) | 0 (0.0) | < 0.01 |
Tobacco use at some point postoperatively | 2 (5.4) | 2 (9.5) | 0 (0.0) | 0.59 |
Average PPD (SD) | 0.24 (0.35) | 0.44 (0.37) | 0.00 (0.00) | < 0.01 |
Reported complication postoperatively | 0.36 | |||
SSI | 1(2.7) | 0 (0.0) | 1 (6.2) | |
Dislocation | 1(2.7) | 1 (4.8) | 0 (0.0) | |
PJI | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Revision surgery | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Outcome score | Overall cohort | Relapsed postop | Abstinent postop | P value |
Number of patients | 37 | 21 | 16 | |
Promis-10 physical function score, Mean (SD) | 46.35 (9.25) | 44.12 (9.52) | 49.27 (8.27) | 0.09 |
Promis-10 mental health score, Mean (SD) | 52.56 (10.60) | 48.58 (11.65) | 57.79 (6.12) | < 0.01 |
KOOS. JR, Mean (SD) | 80.77 (17.58) | 78.36 (19.88) | 86.56 (9.52) | 0.4 |
HOOS. JR, Mean (SD) | 73.53 (18.02) | 63.12 (8.23) | 82.05 (19.63) | 0.02 |
- Citation: Kim BI, O'Donnell J, Wixted CM, Seyler TM, Jiranek WA, Bolognesi MP, Ryan SP. Smoking cessation prior to elective total joint arthroplasty results in sustained abstinence postoperatively. World J Orthop 2024; 15(7): 627-634
- URL: https://www.wjgnet.com/2218-5836/full/v15/i7/627.htm
- DOI: https://dx.doi.org/10.5312/wjo.v15.i7.627